| Literature DB >> 22318157 |
Alaa A-M Abdel-Aziz1, Adel S El-Azab, Hussein I El-Subbagh, Abdulrahman M Al-Obaid, Amer M Alanazi, Mohamed A Al-Omar.
Abstract
Novel series of 1-(arenesulfonyl)imidazolidin-2-one (3a-i) and 1,3-bis(arenesulfonyl)imidazolidin-2-one (5a-i) have been synthesized and tested for their antitumor activity against 60 tumor cell lines taken from nine different organs. A significant inhibition for cancer cells was observed with series 5a-i compounds compared with the series 3a-i which showed a weak inhibition. Compounds 5a-i showed good inhibitory effect at the lung cancer HOP-92 and renal cancer CAKI-1 and UO-31 cell lines. Compound 5e showed remarkable broad-spectrum antitumor activity.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22318157 DOI: 10.1016/j.bmcl.2012.01.036
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823